Osaic Holdings
CTXR icon

Osaic Holdings’s Citius Pharmaceuticals CTXR Stock Holding History

Osaic Holdings’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Sell
2,575
-160
-6% -$108 ﹤0.01% 7350
2026
Q1 		$2.46K Buy
2,735
+1,248
+84% +$1.01K ﹤0.01% 6976
2025
Q4 		$1.16K Hold
1,487
– – ﹤0.01% 7231
2025
Q3 		$1.98K Sell
1,487
-200
-12% -$279 ﹤0.01% 7137
2025
Q2 		$2.68K Buy
1,687
+160
+10% +$147 ﹤0.01% 6829
2025
Q1 		$2.27K Hold
1,527
– – ﹤0.01% 6540
2024
Q4 		$6.11K Sell
1,527
-35,746
-96% -$241K ﹤0.01% 6079
2024
Q3 		$466K Sell
37,273
-20
-0.1% -$337 ﹤0.01% 2935
2024
Q2 		$544K Hold
37,293
– – ﹤0.01% 2704
2024
Q1 		$837K Buy
37,293
+3
+0% +$55 ﹤0.01% 2507
2023
Q4 		$705K Buy
37,290
+34,394
+1,188% +$652K ﹤0.01% 2859
2023
Q3 		$49.6K Buy
2,896
+1,268
+78% +$30.1K ﹤0.01% 5012
2023
Q2 		$48.8K Buy
1,628
+42
+3% +$1.38K ﹤0.01% 4953
2023
Q1 		$46.4K Sell
1,586
-240
-13% -$6.92K ﹤0.01% 5006
2022
Q4 		$36.2K Buy
1,826
+360
+25% +$9.82K ﹤0.01% 5166
2022
Q3 		$44K Buy
1,466
+80
+6% +$2.2K ﹤0.01% 5008
2022
Q2 		$32K Hold
1,386
– – ﹤0.01% 5284
2022
Q1 		$62K Hold
1,386
– – ﹤0.01% 4933
2021
Q4 		$53K Sell
1,386
-120
-8% -$5.44K ﹤0.01% 5100
2021
Q3 		$76K Sell
1,506
-114
-7% -$5.72K ﹤0.01% 4767
2021
Q2 		$141K Sell
1,620
-1,340
-45% -$80.5K ﹤0.01% 4189
2021
Q1 		$131K Buy
2,960
+860
+41% +$34.2K ﹤0.01% 4139
2020
Q4 		$54K Buy
2,100
+1,900
+950% +$49.5K ﹤0.01% 4504
2020
Q3 		$5K Buy
+200
New +$5.65K ﹤0.01% 5554
2020
Q2 		– Sell
-40
Closed -$1K – 6145
2020
Q1 		$1K Buy
+40
New +$845 ﹤0.01% 5820

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Osaic Holdings's CTXR Position: Q2 2026 in Review

Osaic Holdings reduced its Citius Pharmaceuticals (CTXR) stake by 5.9% in Q2 2026, selling an estimated $108 and leaving 2,575 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #7350.

Osaic Holdings first reported a position in CTXR in Q1 2020 and has held it in 25 quarters since. The position peaked at $837K in Q1 2024. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Osaic Holdings held 2,575 shares of Citius Pharmaceuticals worth $1.54K as of Q2 2026.
  • Osaic Holdings sold 160 Citius Pharmaceuticals shares in Q2 2026, an estimated $108.
  • Citius Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7350 holding.
  • Osaic Holdings first reported a position in Citius Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Citius Pharmaceuticals position peaked at $837K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.